Suppr超能文献

肾上腺素作为感染性休克的正性肌力药物:剂量-效应分析

Epinephrine as an inotropic agent in septic shock: a dose-profile analysis.

作者信息

Moran J L, O'Fathartaigh M S, Peisach A R, Chapman M J, Leppard P

机构信息

Queen Elizabeth Hospital, Woodville, South Australia.

出版信息

Crit Care Med. 1993 Jan;21(1):70-7. doi: 10.1097/00003246-199301000-00015.

Abstract

OBJECTIVE

To characterize the acute actions and physiologic dose profile of epinephrine, as a single inotrope, in patients with septic shock.

DESIGN

Prospective clinical study. The relationship between epinephrine dose and cardiovascular variables was analyzed using repeated-measures analysis of variance.

SETTING

ICU in a university teaching hospital.

PATIENTS

Eighteen patients with septic shock, mean age 64 +/- 8 (SD) yrs, and with a mean admission Acute Physiology and Chronic Health Evaluation (APACHE II) score of 23 (range 14 to 35).

INTERVENTIONS

Initial volume loading and the measurement of a baseline hemodynamic profile were followed by the administration of an epinephrine infusion at 3 microgram/min with subsequent increments of 3 micrograms/min and the determination of a hemodynamic profile after each dose increment. Therapy was titrated to clinical goals of perfusion and restoration of premorbid systolic arterial BP.

MEASUREMENTS AND MAIN RESULTS

After volume loading, mean hemodynamic indices were as follows: mean arterial pressure (MAP) 62 +/- 7 mm Hg; cardiac index 3.8 +/- 1.1 L/min/m2; left ventricular stroke work index 25 +/- 11 g.m/m2; oxygen delivery (Do2) index 460 +/- 168 mL/min/m2; and oxygen consumption (VO2) index 165 +/- 64 mL/min/m2. In the dose range of 3 to 18 microgram/min, epinephrine produced linear increases in average heart rate, MAP, cardiac index, left ventricular stroke work index, stroke volume index, VO2, and DO2. No effect was noted on pulmonary artery occlusion pressure (PAOP), mean pulmonary arterial pressure, or systemic vascular resistance index.

CONCLUSIONS

Epinephrine increases DO2 in septic shock by increasing cardiac index without an effect on systemic vascular resistance index or PAOP.

摘要

目的

明确肾上腺素作为单一正性肌力药物在感染性休克患者中的急性作用及生理剂量分布。

设计

前瞻性临床研究。采用重复测量方差分析肾上腺素剂量与心血管变量之间的关系。

地点

大学教学医院的重症监护病房。

患者

18例感染性休克患者,平均年龄64±8(标准差)岁,平均入院急性生理与慢性健康状况评分(APACHE II)为23分(范围14至35分)。

干预措施

初始容量负荷及测量基线血流动力学指标后,以3微克/分钟的速度静脉输注肾上腺素,随后每次递增3微克/分钟,并在每次剂量递增后测定血流动力学指标。治疗根据灌注及恢复病前收缩动脉血压的临床目标进行调整。

测量指标及主要结果

容量负荷后,平均血流动力学指标如下:平均动脉压(MAP)62±7毫米汞柱;心脏指数3.8±1.1升/分钟/平方米;左心室每搏功指数25±11克·米/平方米;氧输送(Do2)指数460±168毫升/分钟/平方米;氧消耗(VO2)指数165±64毫升/分钟/平方米。在3至18微克/分钟的剂量范围内,肾上腺素使平均心率、MAP、心脏指数、左心室每搏功指数、每搏量指数、VO2和Do2呈线性增加。未观察到对肺动脉闭塞压(PAOP)、平均肺动脉压或全身血管阻力指数有影响。

结论

肾上腺素通过增加心脏指数提高感染性休克患者的Do2,而对全身血管阻力指数或PAOP无影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验